Evaheart

EVI was established to gain regulatory approval and commercialize the EVAHEART®2 Left Ventricular Assist System in the North American market and start distribution in Europe. Under an FDA-approved IDE, a bridge-to-transplant (BTT) clinical trial of the EVAHEART®2 LVAS is currently ongoing in US.
Community
Address

6655 Travis St #300
Houston, TX 77030
United States